Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets
Virpax Pharmaceuticals Inc. has raised $6.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2025.
Virpax Pharmaceuticals Inc. is headquartered in Berwyn, United States.
Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets
Virpax Pharmaceuticals Inc. is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Virpax Pharmaceuticals Inc. — Funding & Investors." VCBacked, January 28, 2025, https://www.vcbacked.co/company/virpax-pharmaceuticals-inc. Accessed August 17, 2026.
VCBacked. (2025). Virpax Pharmaceuticals Inc. — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/virpax-pharmaceuticals-inc
{{cite web |title=Virpax Pharmaceuticals Inc. — Funding & Investors |url=https://www.vcbacked.co/company/virpax-pharmaceuticals-inc |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated